Real-time three-dimensional echocardiography evaluation of coronary artery disease after PTCA in patients with left ventricular regional wall motion abnormalities.docVIP

 PAGE \* MERGEFORMAT 6 Real-time three-dimensional echocardiography evaluation of coronary artery disease after PTCA in patients with left ventricular regional wall motion abnormalities [Abstract] Objective To investigate the real-time three-dimensional echocardiography (RT 3DE) in patients with coronary heart disease after percutaneous transluminal coronary angioplasty (PTCA preoperative and postoperative left ventricular regional wall motion abnormalities of clinical value. Methods 12 of myocardial ischemia group myocardial infarction cases and 20 cases were due to coronary artery stenosis in patients with PTCA and stent implantation line, respectively, before surgery 1 d, after 1 w and 3-month line of RT 3DE detection, measurement of left ventricular end diastolic volume (EDV ), end systolic volume (ESV) and left ventricular ejection fraction (EF), and get 17 time left ventricular volume curve and the “bull’s-eye map.” The results of preoperative and postoperative myocardial infarction and ischemic group, EDV, ESV increased, EF value decreased (P lt;0.05), ischemic group was compared with the preoperative 1 w, EDV, ESV narrow, EF increased (P lt;0.05,3 months is still improve, but with a When w was no significant difference (Pgt; 0.05), myocardial infarction group was compared with preoperative 1 w, EDV and ESV has been reduced, EF has increased, but no significant difference (Pgt; 0.05), After 3 months, EDV, ESV was significantly reduced, EF increased significantly after 1 w and there was significant difference (P lt;0.05). myocardial ischemia and myocardial infarction group and 17 segments of time-volume curve and dynamic cattle eye diagram shows the segments after ischemia or infarction improved movement, ischemia group recovered more obvious. Conclusion RT 3DE technology objective, real-time evaluation of left ventricular systolic function and regional wall motion abnormality, can be used as percutaneous coronary artery intervention after an effective